Autism-Related Study Discovers How Drug Interferes With Neuronal Cell Function
Sunday, Aug. 1st 2010 1:12 PM
A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function. It is an important finding because misoprostol is similar in structure to naturally-occurring prostaglandins, which are the key signaling molecules produced by fatty acids in the brain…
Related posts:
- Study Aims To Uncover Source Of Sensory Problems In Autism The way the brain reacts differently to the sense of touch in people with Autism will be examined as part of an innovative Cardiff University study designed to create better understanding of the condition in Autism....
- Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders Study Marks The Emergence Of Disease-Modifying Treatments For Autism Spectrum Disorders...
- Study Linking Autism To MMR Vaccine “An Elaborate Fraud” Study Linking Autism To MMR Vaccine "An Elaborate Fraud"...
- Study Shows Promise For New Drug To Treat Fragile X Study Shows Promise For New Drug To Treat Fragile X...
- Research Provides Important Insight Into ‘Systemizing’ Theory Of Autism A new study from Cambridge University has for the first time found that autism diagnoses are more common in an IT-rich region. The Medical Research Council (MRC) funded study, published in the Journal of Autism and Developmental Disorders, has important implications for service provision in different regions and for the ‘hyper-systemizing’ theory of autism....
- Seaside Therapeutics Initiates Phase 2b Study Of STX209 In Autism Spectrum Disorders Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 2b study to evaluate the effects of STX209 (arbaclofen) on social impairment in children, adolescents and adults (ages 5 to 21) with autism spectrum disorders (ASD). The Company announced positive results from an open-label Phase 2a study of STX209 in September of […]...
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- Pitt Study Examines Environmental Risk Factors For Childhood Autism The University of Pittsburgh Graduate School of Public Health (GSPH) has launched a multi-year study to help identify environmental and other factors that may put children at risk for developing conditions within the autism spectrum disorders (ASDs)....
- Youth Buffered Against Risk Factors Related To Drug Abuse By Healthy Family Relationships And Religious Involvement American-Indian adolescents continue to have the highest rates of illicit drug use among all ethnic groups. Although previous research has found that increasing adolescent exposure to protective factors can reduce their risk for substance abuse, this has not been thoroughly examined in American-Indian adolescents…...
- Disruption Of Neural Activity In Autistic Toddlers A new study provides valuable insight into the neuropathology of early autism development by imaging the brains of naturally sleeping toddlers. The research, published by Cell Press in the June 24 issue of the journal Neuron, identifies a brain abnormality observed at the very beginning stages of autism that may aid in early diagnosis of […]...
- Autism Families With New Pregnancies Sought For Vitamin D Research Associate Professor Emeritus of Psychiatry and Pediatrics (OHSU, Portland, Oregon) is seeking roughly 50-100 volunteer families to participate in a vitamin D study. The goal of the study is to find out whether giving Vitamin D to the pregnant mother, who already has had at least one previous child with autism, can prevent the recurrence […]...
- Weaker Brain "Sync" May Be Early Sign Of Autism In a novel imaging study of sleeping toddlers, scientists at the University of California, San Diego Autism Center of Excellence report that a diminished ability of a young brain’s hemispheres to “sync” with one another could be a powerful, new biological marker of autism, one that might enable an autism diagnosis at a very young […]...
- McMaster Researchers Say Routine Screening For Autism Not Needed Proposals recommending routine screening of all children for autism gets a thumbs down from researchers at McMaster University. In a study in the online edition of the journal Pediatrics, the researchers say there is “not enough sound evidence to support the implementation of a routine population-based screening program for autism....
- New Technology Reveals A Unique Vocal Signature In Autism A new automated vocal analysis technology could fundamentally change the study of language development as well as the screening for autism spectrum disorders and language delay, reports a study in the July 19 online Proceedings of the National Academy of Sciences…...
- Johns Hopkins Researchers Create New Mouse Model Of Autism In an effort to unravel the tangled biology of autism, Johns Hopkins scientists have created a mouse model that mimics a human mutation of a gene known to be associated with autism spectrum disorders. Experiments with the engineered mouse reveal a molecular mechanism by which mutations of the gene named Shank3 affect the brain and […]...
Posted on Sunday, Aug. 1st 2010 1:12 PM | by Share of Cost | in Share of Cost | No Comments »